A complete application in a minute
Tailored resume and cover letter, ready to send.
Hartmann Young Limited seeks a Managing Director & Site Head to lead a US peptide manufacturing operation undergoing expansion. You will own site strategy, operating performance and leadership development while guiding the readiness of a new facility.
The role requires a seasoned executive with strong peptide manufacturing background, regulatory know-how and hands-on capital expansion experience. This is a high-impact, site-level leadership assignment within a global CDMO.
Location: Southeast USA (South Carolina)
Industry: Pharmaceutical CDMO | Peptide Manufacturing
Position: Managing Director & Site Head
Employment: Full-time | Site-based
Hartmann Young is partnering with an established global pharmaceutical CDMO to appoint a Managing Director & Site Head for a US peptide manufacturing operation undergoing significant expansion.
This is a senior executive leadership opportunity with full responsibility for site operations, financial performance, organisational development and the operational readiness of a new peptide manufacturing facility.
The successful candidate will lead an established manufacturing operation while developing the infrastructure, leadership team and operational capabilities required to support future growth.
This role would suit an experienced Site Head, General Manager or Managing Director with a strong background in peptide manufacturing, regulated pharmaceutical operations and large-scale facility expansion.
This is an opportunity to lead a growing US peptide manufacturing operation at a pivotal stage of its development.
The incoming Managing Director will have significant influence over the site's long-term direction, combining leadership of existing operations with responsibility for building the team, systems and capabilities required for a major manufacturing expansion.
The position offers substantial strategic visibility within an international CDMO organisation and the opportunity to play a central role in expanding peptide manufacturing capabilities.